KOR agonists reduced LPS-induced iNOS, COX-2, TNF-α, and IL-1β over-expression in alveolar macrophages within 2 hours after LPS activation, and such effects can be partially blocked by KOR antagonist, suggesting KOR might play critical role in modulating the acute phase of pulmonary inflammation via macrophages. Here, OPRK1 is linked to inflammatory response.